BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15655143)

  • 21. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
    Alexiades-Armenakas M
    J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urticaria-like reaction secondary to photodynamic therapy in 2 pediatric patients.
    Miguélez A; Martín-Santiago A; Bauzá A; Gilaberte Y
    Actas Dermosifiliogr; 2013 Oct; 104(8):727-9. PubMed ID: 23954045
    [No Abstract]   [Full Text] [Related]  

  • 23. Photodynamic therapy as a new treatment of cutaneous leishmaniasis.
    Ghaffarifar F; Jorjani O; Mirshams M; Miranbaygi MH; Hosseini ZK
    East Mediterr Health J; 2006 Nov; 12(6):902-8. PubMed ID: 17333838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy using light-emitting diodes for the treatment of viral warts.
    Ohtsuki A; Hasegawa T; Hirasawa Y; Tsuchihashi H; Ikeda S
    J Dermatol; 2009 Oct; 36(10):525-8. PubMed ID: 19785705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
    Naidenov N; Dencheva R; Tsankov N
    Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer.
    Garcia-Zuazaga J; Cooper KD; Baron ED
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):791-800. PubMed ID: 16221049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population.
    Wang YS; Tay YK; Kwok C; Tan E
    Int J Dermatol; 2007 Nov; 46(11):1180-4. PubMed ID: 17988339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical photodynamic therapy in clinical dermatology.
    Kormeili T; Yamauchi PS; Lowe NJ
    Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Schleyer V; Szeimies RM; Zwingers T; Hönigsmann H; Tanew A
    Br J Dermatol; 2005 Feb; 152(2):279-83. PubMed ID: 15727639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features.
    Kaviani A; Ataie-Fashtami L; Fateh M; Sheikhbahaee N; Ghodsi M; Zand N; Djavid GE
    Lasers Surg Med; 2005 Jun; 36(5):377-82. PubMed ID: 15965991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodynamic therapy for acne vulgaris: a pilot study of the dose-response and mechanism of action.
    Hörfelt C; Stenquist B; Larkö O; Faergemann J; Wennberg AM
    Acta Derm Venereol; 2007; 87(4):325-9. PubMed ID: 17598035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
    Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study.
    Raspagliesi F; Fontanelli R; Rossi G; Ditto A; Solima E; Hanozet F; Kusamura S
    Gynecol Oncol; 2006 Nov; 103(2):581-6. PubMed ID: 16793128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia.
    Shafirstein G; Friedman A; Siegel E; Moreno M; Bäumler W; Fan CY; Morehead K; Vural E; Stack BC; Suen JY
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1117-23. PubMed ID: 22106236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.
    Oseroff AR; Blumenson LR; Wilson BD; Mang TS; Bellnier DA; Parsons JC; Frawley N; Cooper M; Zeitouni N; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):417-26. PubMed ID: 16788928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nevoid basal cell carcinoma syndrome versus generalized basaloid follicular hamartoma syndrome.
    Ackerman AB
    J Cutan Pathol; 2009 May; 36(5):603; author reply 604. PubMed ID: 19476535
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
    Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
    Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy for superficial bladder cancer.
    Shackley DC; Briggs C; Whitehurst C; Betts CD; O'Flynn KJ; Clarke NW; Moore JV
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):523-30. PubMed ID: 12113084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-aminolevulinic acid photodynamic therapy and excision surgery for nevoid basal cell carcinoma syndrome with multiple basal cell carcinomas and PTCH1 mutation.
    Li C; Chen P; Li Z; Wang Y; He S; Shi M; Wang Q; Xu M; Li Q; Chen H; Zeng K; Liang J; Zhang X
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101968. PubMed ID: 32835883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.